We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Phenotypic Screening – Advances in Technologies and Techniques

Article   Oct 25, 2019 | by Joanna Owens, PhD

 
Phenotypic Screening – Advances in Technologies and Techniques
 
 
 

RELATED ARTICLES

Could Cannabinoids Be Used To Treat PTSD?

Article

Effective treatments for post-traumatic stress disorder (PTSD) have proved extremely elusive to researchers. For some, the legalisation of cannabis could present an opportunity to develop new therapies for PTSD.We talked to Allied Corp’s CEO Calum Hughes about cannabis’s potential for PTSD therapeutics.

READ MORE

Technology Networks Explores the CRISPR Revolution: An Interview With Professor Glenn Cohen, World-leading Expert on Bioethics

Article

In this feature of Technology Networks Explores the CRISPR Revolution, we interview Professor Glenn Cohen, director of Harvard Law School's Petrie-Flom Center for Health Law Policy, Biotechnology and Bioethics.

READ MORE

The Promise of in vitro 3D Organoid Models: Meeting the ADME-Tox Testing Needs of the Pharmaceutical Industry

Article

For many years, biologists have relied on in vitro 2-dimensional (2D) cell culture models to perform preclinical ADME-Tox assays. While these models are useful for informing aspects of drug discovery, such as cytotoxicity, they are limited in their translatability to drug metabolism and toxicity in humans. Recently, in vitro 3-dimensional (3D) organoid models that more closely mimic human biological systems show promise in supporting ADME-Tox studies in the early stages of the drug development process, compared to their 2D counterparts.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Genomics Research

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE